Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity
Oxaliplatin is a third-generation platinum-based anticancer drug that is widely used as first-line treatment for colorectal carcinoma. Patients treated with oxaliplatin develop an acute peripheral pain several hours after treatment, mostly characterized by cold allodynia as well as a long-term chron...
Main Authors: | Vittoria Rimola, Tabea Osthues, Vanessa Königs, Gerd Geißlinger, Marco Sisignano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4962 |
Similar Items
-
Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
by: Aerziguli Aierken, et al.
Published: (2021-11-01) -
Topical TRPM8 Agonist for Relieving Neuropathic Ocular Pain in Patients with Dry Eye: A Pilot Study
by: Hyeon Jeong Yoon, et al.
Published: (2021-01-01) -
Shakuyakukanzoto attenuates oxaliplatin-induced cold dysesthesia by inhibiting the expression of transient receptor potential melastatin 8 in mice
by: Tsugunobu Andoh, et al.
Published: (2017-01-01) -
β–Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models
by: Cristina Martín-Escura, et al.
Published: (2022-02-01) -
Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models
by: Kanako So, et al.
Published: (2015-03-01)